Bristlecone Advisors’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-38,664
Closed -$190K 279
2023
Q4
$190K Sell
38,664
-15,609
-29% -$76.4K 0.02% 268
2023
Q3
$296K Sell
54,273
-2,287
-4% -$18.3K 0.03% 210
2023
Q2
$524K Buy
56,560
+7,819
+16% +$66.1K 0.05% 172
2023
Q1
$401K Buy
48,741
+1,136
+2% +$12.5K 0.04% 189
2022
Q4
$530K Buy
47,605
+4,485
+10% +$52.1K 0.07% 164
2022
Q3
$511K Buy
43,120
+1,142
+3% +$17.3K 0.07% 163
2022
Q2
$641K Buy
41,978
+10,739
+34% +$193K 0.08% 148
2022
Q1
$660K Buy
31,239
+3,086
+11% +$66.5K 0.08% 140
2021
Q4
$665K Buy
28,153
+2,319
+9% +$49.7K 0.08% 145
2021
Q3
$518K Buy
25,834
+1,640
+7% +$33.6K 0.07% 152
2021
Q2
$486K Buy
24,194
+771
+3% +$16.5K 0.07% 149
2021
Q1
$498K Buy
23,423
+4,267
+22% +$91.8K 0.08% 144
2020
Q4
$417K Buy
19,156
+5,429
+40% +$106K 0.07% 152
2020
Q3
$242K Buy
+13,727
New +$255K 0.04% 166

Other funds holding MPT

Bristlecone Advisors's MPT Position: Q1 2024 in Review

Bristlecone Advisors sold out of Medical Properties Trust (MPT) in Q1 2024, closing a stake of 38,664 shares — an estimated $190K sold.

Bristlecone Advisors first reported a position in MPT in Q3 2020 and held it in 14 quarters. The position peaked at $665K in Q4 2021. 510 funds tracked by Wall St. Rank hold MPT as of Q1 2024.

  • Bristlecone Advisors reported no remaining Medical Properties Trust position as of Q1 2024 after selling out during the quarter.
  • Bristlecone Advisors sold 38,664 Medical Properties Trust shares in Q1 2024, an estimated $190K.
  • Bristlecone Advisors first reported a position in Medical Properties Trust in Q3 2020 and held it in 14 quarters.
  • Bristlecone Advisors's Medical Properties Trust position peaked at $665K in Q4 2021.
  • 510 funds tracked by Wall St. Rank held Medical Properties Trust as of Q1 2024.

Based on Bristlecone Advisors's 13F filing for Q1 2024, filed 22 Apr 2024.